Percentage of correct responders (95%CI) | |||||||
---|---|---|---|---|---|---|---|
Correct items of the surveyed core principles of predictive epigenetic testing for female cancer risks | All Countries N = 1675 | Czech Republic n = 356 | Germany n = 335 | United Kingdom n = 323 | Italy n = 338 | Sweden n = 323 | p-value* |
The predictive epigenetic test for female cancer risks targets a woman’s risk for breast, ovarian, cervical, and endometrial cancer. | 94.6 (93.4, 95.6) | 93.5 (90.5, 95.9) | 98.5 (96.6, 99.5) | 96.0 (93.2, 97.8) | 89.1 (85.2, 92.2) | 96.0 (93.2, 97.8) | <.001 |
With a lower-than-average risk result, a woman could consider having less screening and consequently may reduce her likelihood of overdiagnosis and false alarms. | 57.4 (55.0, 59.8) | 43.0 (37.8, 48.3) | 57.0 (51.5, 62.4) | 81.1 (76.4, 85.2) | 62.1 (56.7, 67.3) | 44.9 (39.5, 50.5) | <.001 |
With a higher-than-average risk result, a woman could consider having more screening or preventive measure in order to reduce her likelihood of dying from cancer. | 76.2 (74.1, 78.2) | 47.5 (42.2, 52.8) | 83.9 (79.5, 87.7) | 87.6 (83.5, 91.0) | 76.3 (71.4, 80.8) | 88.2 (84.2, 91.5) | <.001 |
Our environment and lifestyle is changing the epigenome of our cells. | 75.3 (73.2, 77.4) | 66.3 (61.1, 71.2) | 79.1 (74.4, 83.3) | 87.3 (83.2, 90.7) | 72.8 (67.7, 77.5) | 72.1 (66.9, 77.0) | <.001 |